SCHEMBL7716737

SCHEMBL7716737

CN1CCN(c2ncc(Oc3ccc(Cl)cc3)c(N3CCN(CCO)CC3)n2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
KDM4E B2RXH2 3/20 0.48
HTT P42858 3/20 0.48
HRH4 Q9H3N8 4/20 0.46
HTR3A P46098 1/20 0.44
LMNA P02545 3/20 0.43
EGLN1 Q9GZT9 1/20 0.41
SRC P12931 1/20 0.41
HTR2A P28223 1/20 0.40
CYP3A4 P08684 2/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
MAPT P10636 4/20 0.39
TSHR P16473 4/20 0.39
USP2 O75604 2/20 0.39
CASP1 P29466 2/20 0.39
CASP7 P55210 2/20 0.39
HSD17B10 Q99714 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7714708 0.96 LMNA (0.46) ALDH1A1KDM4EHTTHRH4LMNA
SCHEMBL7714147 0.93 ALDH1A1 (0.44) ALDH1A1KDM4EHTTHRH4LMNA
SCHEMBL7714381 0.93 MEN1 (0.49) ALDH1A1KDM4EHTTLMNAEGLN1
SCHEMBL7712468 0.92 MEN1 (0.51) ALDH1A1KDM4EHTTLMNAEGLN1
SCHEMBL7712503 0.90 MEN1 (0.49) ALDH1A1KDM4EHTTLMNASRC
SCHEMBL7708411 0.89 SRC (0.41) ALDH1A1KDM4EHTTLMNASRC
SCHEMBL7716698 0.89 HTR1A (0.46) ALDH1A1KDM4EHTTLMNAHTR2A
SCHEMBL8139672 0.87 MAPT (0.45) ALDH1A1KDM4EHTTHRH4LMNA
SCHEMBL7716722 0.87 HRH4 (0.51) ALDH1A1HRH4HTR3AEGLN1CYP3A4
SCHEMBL7714501 0.86 LMNA (0.46) ALDH1A1KDM4EHTTHRH4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US claimed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP claimed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO claimed
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP disclosed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO disclosed